Welcome!

News Feed Item

Liberator Medical Reports Revenue of $18.6 Million for Its Fiscal First Quarter Ended December 31, 2013

The Company Reports Net Income of $2.1 Million, or $0.04 per Share, for the Quarter

STUART, FL--(Marketwired - February 12, 2014) - Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) today announced the financial results for its fiscal first quarter ended December 31, 2013. Financial highlights are summarized below:

                                                                      
Dollars in thousands               Q1 FY2014     Q1 FY2013     Change 
                                  -----------   -----------   --------
                                                                      
Net sales                         $    18,637   $    17,551       6.2%
                                                                      
Gross profit                           11,755        10,978       7.1%
                                                                      
Operating income                        3,500         2,258      55.0%
                                                                      
Net income                        $     2,120   $     1,352      56.8%
                                                                      

Net sales for the three months ended December 31, 2013, increased by $1,086,000, or 6.2%, to $18,637,000, compared with net sales of $17,551,000 for the three months ended December 31, 2012. The increase in net sales was due to our continued emphasis on our direct response advertising campaign to acquire new customers and on customer service to maximize the reorder rates for our recurring customer base.

Gross profit for the three months ended December 31, 2013, increased by $777,000, or 7.1%, to $11,755,000, compared with gross profit of $10,978,000 for the three months ended December 31, 2012. The increase is attributed to increased sales volumes and a reduction in product costs for the three months ended December 31, 2013, compared with the three months ended December 31, 2012.

Income from operations for the three months ended December 31, 2013, increased by $1,242,000, or 55.0%, to $3,500,000, compared with the three months ended December 31, 2012. The increase in operating income is attributed to increased gross profit driven by our increased sales volumes at reduced levels of operating expenses.

Net income for the first quarter of fiscal year 2014 was $2,120,000, or $0.04 per diluted share, compared with net income of $1,352,000, or $0.03 per diluted share, for the first quarter of fiscal year 2013.

The Company had cash of $12,195,000 at December 31, 2013, compared with cash of $12,453,000 at September 30, 2013, a decrease of $258,000. The decrease in cash for the three months ended December 31, 2013, was due to $1,518,000 of cash used in financing activities, primarily cash dividends paid to shareholders, and $47,000 of net cash used in investing activities, partially offset by $1,307,000 of cash provided by operating activities.

Other Significant Events for the First Quarter of Fiscal Year 2014

  • On November 20, 2013, the Company's common stock was listed and began trading on the NYSE MKT exchange, increasing visibility and shareholder liquidity.
  • During the first quarter of fiscal year 2014, the Company declared a quarterly cash dividend of $0.03 per common share.

Mark Libratore, the Company's President and CEO, commented, "Our financial results for the first quarter of fiscal year 2014 demonstrate our continued emphasis on growing our customer base, increasing our earnings, and improving our operating margins. The cash generated from our operations provides a quarterly cash dividend to our shareholders and the flexibility for the Company to grow through a combination of our direct response advertising efforts and strategic acquisitions that allow us to acquire new customers at competitive rates.

We will continue to manage the levels of our direct response advertising spend, implement process improvements, and explore potential acquisition targets to grow our business and increase operating margins during fiscal year 2014."

Stay up-to-date with current events by visiting Liberator Medical's website at www.liberatormedical.com or by joining the Company's E-Mail Alert List. Join by clicking the following link www.LBMH-IR.com

About Liberator Medical Holdings, Inc.

Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical Supply, Inc., established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. Accredited by The Joint Commission, our Company's unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions. Liberator is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Liberator's revenue primarily comes from supplying products to meet the rapidly growing requirements of general medical supplies, diabetes supplies, catheters, ostomy supplies and mastectomy fashions. Liberator communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.

Safe Harbor Statement

In this press release and in related comments by our management, our use of the words "expect," "anticipate," "possible," "potential," "target," "believe," "commit," "intend," "continue," "may," "would," "could," "should," "project," "projected," "positioned" or similar expressions is intended to identify forward-looking statements that represent our current judgment about possible future events. We believe these judgments are reasonable, but these statements are not guarantees of any events or financial results, and our actual results may differ materially due to a variety of important factors. Such risks and uncertainties may include, but are not limited to, regulatory limitations on the medical industry in general, working capital constraints, fluctuations in customer demand and commitments, fluctuation in quarterly results, introduction of new services and products, commercial acceptance and viability of new services and products, pricing and competition, reliance upon subcontractors and vendors, the timing of new technology and product introductions, and the risk of early obsolescence of our products. Liberator's most recent annual report on Form 10-K and quarterly reports on Form 10-Q provide information about these and other factors, which we may revise or supplement in future reports filed with the Securities and Exchange Commission.

                                                                            
                                                                            
             Liberator Medical Holdings, Inc. and Subsidiaries              
                   Condensed Consolidated Balance Sheets                    
        As of December 31, 2013 (unaudited) and September 30, 2013          
              (In thousands, except dollar per share amounts)               
                                                                            
                                              December 31,    September 30, 
                                                  2013            2013      
                                             --------------  -------------- 
                    Assets                                                  
Current Assets:                                                             
  Cash                                       $       12,195  $       12,453 
  Accounts receivable, net of allowances of                                 
   $4,745 and $4,502, respectively                    9,589           7,836 
  Inventory, net of allowance for obsolete                                  
   inventory of $321 and $308, respectively           2,482           2,187 
  Deferred tax assets                                 2,112           2,067 
  Prepaid and other current assets                      626             219 
                                             --------------  -------------- 
  Total Current Assets                               27,004          24,762 
Property and equipment, net of accumulated                                  
 depreciation of $3,637 and $3,492,                                         
 respectively                                           944           1,044 
Deferred advertising, net                            23,311          22,705 
Intangible assets, net of accumulated                                       
 amortization of $194 and $169, respectively            388             414 
Other assets                                            170             174 
                                             --------------  -------------- 
Total Assets                                 $       51,817  $       49,099 
                                             --------------  -------------- 
                                                                            
     Liabilities and Stockholders' Equity                                   
Current Liabilities:                                                        
  Accounts payable                           $        6,381  $        4,915 
  Accrued liabilities                                 1,569           1,354 
  Dividends payable                                   1,572           1,569 
  Income tax payable                                  1,681           1,195 
  Other current liabilities                              93             111 
                                             --------------  -------------- 
    Total Current Liabilities                        11,296           9,144 
Deferred tax liabilities                              8,487           8,561 
Credit line facility                                  1,500           1,500 
Other long-term liabilities                              51              63 
                                             --------------  -------------- 
Total Liabilities                                    21,334          19,268 
                                             --------------  -------------- 
                                                                            
Stockholders' Equity:                                                       
Common stock, $.001 par value, 200,000 shares                               
 authorized, 52,757 and 52,637 shares issued,                               
 respectively; 52,403 and 52,283 shares                                     
 outstanding at December 31, 2013, and                                      
 September 30, 2013, respectively                        53              53 
Additional paid-in capital                           35,215          35,111 
Accumulated deficit                                  (4,305)         (4,853)
Treasury stock, at cost; 354 shares at                                      
 December 31, 2013, and September 30, 2013             (480)           (480)
                                             --------------  -------------- 
Total Stockholders' Equity                           30,483          29,831 
                                             --------------  -------------- 
Total Liabilities and Stockholders' Equity   $       51,817  $       49,099 
                                             ==============  ============== 
                                                                            
                                                                            

See accompanying notes to unaudited condensed consolidated financial statements.

                                                                            
                                                                            
             Liberator Medical Holdings, Inc. and Subsidiaries              
              Condensed Consolidated Statements of Operations               
           For the three months ended December 31, 2013 and 2012            
                                (Unaudited)                                 
                  (in thousands, except per share amounts)                  
                                                                            
                                                      Three Months Ended    
                                                         December 31,       
                                                   ------------------------ 
                                                       2013         2012    
                                                   -----------  ----------- 
                                                                            
Net Sales                                          $    18,637  $    17,551 
                                                                            
Cost of Sales                                            6,882        6,573 
                                                   -----------  ----------- 
                                                                            
Gross Profit                                            11,755       10,978 
                                                   -----------  ----------- 
                                                                            
Operating Expenses:                                                         
  Payroll, taxes and benefits                            3,657        3,843 
  Advertising                                            2,326        2,203 
  Bad debts                                                824        1,278 
  Depreciation and amortization                            171          164 
  General and administrative                             1,277        1,232 
                                                   -----------  ----------- 
Total Operating Expenses                                 8,255        8,720 
                                                   -----------  ----------- 
                                                                            
Income from Operations                                   3,500        2,258 
                                                   -----------  ----------- 
                                                                            
Other Expenses                                             (13)         (21)
                                                   -----------  ----------- 
                                                                            
Income before Income Taxes                               3,487        2,237 
                                                                            
Provision for Income Taxes                               1,367          885 
                                                   -----------  ----------- 
                                                                            
Net Income                                         $     2,120  $     1,352 
                                                   ===========  =========== 
                                                                            
Basic earnings per share:                                                   
Weighted average shares outstanding                     52,358       48,147 
Earnings per share                                 $      0.04  $      0.03 
                                                                            
Diluted earnings per share:                                                 
Weighted average shares outstanding                     53,228       52,143 
Earnings per share                                 $      0.04  $      0.03 
                                                                            
Dividends declared per common share                $      0.03  $         - 
                                                                            

See accompanying notes to unaudited condensed consolidated financial statements.

                                                                            
                                                                            
             Liberator Medical Holdings, Inc. and Subsidiaries              
              Condensed Consolidated Statements of Cash Flows               
           For the three months ended December 31, 2013 and 2012            
                                (Unaudited)                                 
                               (in thousands)                               
                                                      Three Months Ended    
                                                         December 31,       
                                                   ------------------------ 
                                                       2013         2012    
                                                   -----------  ----------- 
Cash flow from operating activities:                                        
  Net Income                                       $     2,120  $     1,352 
  Adjustments to reconcile net income to net cash                           
   provided by operating activities:                                        
    Depreciation and amortization                        2,482        2,310 
    Equity based compensation                               32           10 
    Provision for doubtful accounts and contractual                         
     adjustments                                         1,027        1,335 
    Deferred income taxes                                 (120)         805 
    Reserve for inventory obsolescence                      13           53 
  Changes in operating assets and liabilities:                              
    Accounts receivable                                 (2,779)        (169)
    Deferred advertising                                (2,918)      (2,753)
    Inventory                                             (307)         148 
    Other assets                                          (402)         (57)
    Accounts payable                                     1,952       (2,013)
    Accrued liabilities                                    215          393 
    Other liabilities                                       (8)           3 
                                                   -----------  ----------- 
Net Cash Flow Provided by Operating Activities           1,307        1,417 
                                                   -----------  ----------- 
                                                                            
Cash flow from investing activities:                                        
  Purchase of property and equipment                       (51)        (308)
  Proceeds from sale of property and equipment               4            - 
                                                   -----------  ----------- 
Net Cash Flow Used in Investing Activities                 (47)        (308)
                                                   -----------  ----------- 
                                                                            
Cash flow from financing activities:                                        
  Proceeds from employee stock purchase plan                 -           13 
  Proceeds from exercise of employee stock options          72            - 
  Cash dividends paid                                   (1,569)           - 
  Payments of capital lease obligations                    (22)         (17)
                                                   -----------  ----------- 
Net Cash Flow Used in Financing Activities              (1,518)          (4)
                                                   -----------  ----------- 
                                                                            
Net increase (decrease) in cash                           (258)       1,105 
                                                                            
Cash at beginning of period                             12,453        3,326 
                                                   -----------  ----------- 
Cash at end of period                              $    12,195  $     4,431 
                                                   ===========  =========== 
                                                                            
Supplemental disclosure of cash flow information:                           
Cash paid for interest                             $        15  $        21 
Cash paid for income taxes                         $     1,000  $         5 
                                                                            
Supplemental schedule of non-cash financing                                 
 activities:                                                                
Cash dividends declared, but not yet paid          $     1,572  $         - 
                                                                            

See accompanying notes to unaudited condensed consolidated financial statements.

Contacts:

Individual Investor Relations Contact
WSR Communications
772-219-7525
[email protected]
http://wsrcommunications.ir.stockpr.com/liberatormedical

Institutional Investor Contact
Lyn Davis
Littlebanc Advisors, LLC
561-948-3005
[email protected]
www.littlebanc.com

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
SYS-CON Events announced today that NetApp has been named “Bronze Sponsor” of SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. NetApp is the data authority for hybrid cloud. NetApp provides a full range of hybrid cloud data services that simplify management of applications and data across cloud and on-premises environments to accelerate digital transformation. Together with their partners, NetApp emp...
SYS-CON Events announced today that Avere Systems, a leading provider of enterprise storage for the hybrid cloud, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Avere delivers a more modern architectural approach to storage that doesn't require the overprovisioning of storage capacity to achieve performance, overspending on expensive storage media for inactive data or the overbui...
The session is centered around the tracing of systems on cloud using technologies like ebpf. The goal is to talk about what this technology is all about and what purpose it serves. In his session at 21st Cloud Expo, Shashank Jain, Development Architect at SAP, will touch upon concepts of observability in the cloud and also some of the challenges we have. Generally most cloud-based monitoring tools capture details at a very granular level. To troubleshoot problems this might not be good enough.
The dynamic nature of the cloud means that change is a constant when it comes to modern cloud-based infrastructure. Delivering modern applications to end users, therefore, is a constantly shifting challenge. Delivery automation helps IT Ops teams ensure that apps are providing an optimal end user experience over hybrid-cloud and multi-cloud environments, no matter what the current state of the infrastructure is. To employ a delivery automation strategy that reflects your business rules, making r...
Most technology leaders, contemporary and from the hardware era, are reshaping their businesses to do software. They hope to capture value from emerging technologies such as IoT, SDN, and AI. Ultimately, irrespective of the vertical, it is about deriving value from independent software applications participating in an ecosystem as one comprehensive solution. In his session at @ThingsExpo, Kausik Sridhar, founder and CTO of Pulzze Systems, will discuss how given the magnitude of today's applicati...
Smart cities have the potential to change our lives at so many levels for citizens: less pollution, reduced parking obstacles, better health, education and more energy savings. Real-time data streaming and the Internet of Things (IoT) possess the power to turn this vision into a reality. However, most organizations today are building their data infrastructure to focus solely on addressing immediate business needs vs. a platform capable of quickly adapting emerging technologies to address future ...
Data scientists must access high-performance computing resources across a wide-area network. To achieve cloud-based HPC visualization, researchers must transfer datasets and visualization results efficiently. HPC clusters now compute GPU-accelerated visualization in the cloud cluster. To efficiently display results remotely, a high-performance, low-latency protocol transfers the display from the cluster to a remote desktop. Further, tools to easily mount remote datasets and efficiently transfer...
In a recent survey, Sumo Logic surveyed 1,500 customers who employ cloud services such as Amazon Web Services (AWS), Microsoft Azure, and Google Cloud Platform (GCP). According to the survey, a quarter of the respondents have already deployed Docker containers and nearly as many (23 percent) are employing the AWS Lambda serverless computing framework. It’s clear: serverless is here to stay. The adoption does come with some needed changes, within both application development and operations. Tha...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, will lead you through the exciting evolution of the cloud. He'll look at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering ...
Companies are harnessing data in ways we once associated with science fiction. Analysts have access to a plethora of visualization and reporting tools, but considering the vast amount of data businesses collect and limitations of CPUs, end users are forced to design their structures and systems with limitations. Until now. As the cloud toolkit to analyze data has evolved, GPUs have stepped in to massively parallel SQL, visualization and machine learning.
We all know that end users experience the Internet primarily with mobile devices. From an app development perspective, we know that successfully responding to the needs of mobile customers depends on rapid DevOps – failing fast, in short, until the right solution evolves in your customers' relationship to your business. Whether you’re decomposing an SOA monolith, or developing a new application cloud natively, it’s not a question of using microservices – not doing so will be a path to eventual b...
Enterprises are adopting Kubernetes to accelerate the development and the delivery of cloud-native applications. However, sharing a Kubernetes cluster between members of the same team can be challenging. And, sharing clusters across multiple teams is even harder. Kubernetes offers several constructs to help implement segmentation and isolation. However, these primitives can be complex to understand and apply. As a result, it’s becoming common for enterprises to end up with several clusters. Thi...
SYS-CON Events announced today that Taica will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. TAZMO technology and development capabilities in the semiconductor and LCD-related manufacturing fields are among the best worldwide. For more information, visit https://www.tazmo.co.jp/en/.
SYS-CON Events announced today that TidalScale will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. TidalScale is the leading provider of Software-Defined Servers that bring flexibility to modern data centers by right-sizing servers on the fly to fit any data set or workload. TidalScale’s award-winning inverse hypervisor technology combines multiple commodity servers (including their ass...
SYS-CON Events announced today that Avere Systems, a leading provider of hybrid cloud enablement solutions, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Avere Systems was created by file systems experts determined to reinvent storage by changing the way enterprises thought about and bought storage resources. With decades of experience behind the company’s founders, Avere got its ...